发明申请
- 专利标题: Compounds
-
申请号: US11361599申请日: 2006-02-24
-
公开(公告)号: US20060199804A1公开(公告)日: 2006-09-07
- 发明人: Marc Hummersone , Sylvie Gomez , Keith Menear , Xiao-Ling Cockcroft , Graeme Smith
- 申请人: Marc Hummersone , Sylvie Gomez , Keith Menear , Xiao-Ling Cockcroft , Graeme Smith
- 申请人地址: GB Cambridge
- 专利权人: Kudos Pharmaceuticals Ltd
- 当前专利权人: Kudos Pharmaceuticals Ltd
- 当前专利权人地址: GB Cambridge
- 优先权: GB0503962.3 20050225
- 主分类号: A61K31/551
- IPC分类号: A61K31/551 ; A61K31/541 ; A61K31/5377 ; A61K31/53 ; A61K31/506 ; C07D417/02 ; C07D413/02 ; C07D403/02
摘要:
Compounds of formula I: A-B-C (I)and isomers, salts, solvates, chemically protected forms, and prodrugs thereof wherein: B is selected from the group consisting of: where RN is H or Me; or B is a divalent C5 heterocyclic residue containing one or two ring heteroatoms; A is: RA3 and RA5 are independently selected from halo, ORO and RAC, where RO is H or Me, and RAC is H or C1-4 alkyl; XA is selected from N and CRA4, where RA4 is selected from H, ORO, CH2OH, CO2H, NHSO2Me and NHCOMe; RA2 and RA6 are independently selected from H, halo and ORO; or RA3 and RA4 together with the carbon atoms to which they are attached, or RA2 and RA3 together with the carbon atoms to which they are attached, may form a C5-6 heterocylic or heteroaromatic ring, containing at least one nitrogen ring atom; where if X is not N, 1, 2, or 3 of RA2 to RA6 are not H; C is: where X is selected from N and CH, Y is selected from N and CH, and Z is selected from N and CRC6; RC3 is selected from H, halo and an optionally substituted N-containing C5-7 heterocyclic group; RC5 is a group selected from: which group may be selected by one or two C1-4 alkyl groups or a carboxy group; RC6 is H; or, when X and Y are N, RC5 and RC6 (when Z is CRC6) together with the carbon atoms to which they are attached may form a fused C6 aromatic ring selected from the group consisting of:
公开/授权文献
- US07504397B2 mTOR inhibitor compounds 公开/授权日:2009-03-17
信息查询